Vicky Makker
- Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023/10/23 by Funda Meric‐Bernstam, Funda Meric-Bernstam, Vicky Makker +22 · 3 citations
Medicine · #Advanced Breast Cancer Therapies #Cancer Treatment and Pharmacology #HER2/EGFR in Cancer Research
- Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
2024/06/01 by Vicky Makker, José Alejandro Pérez Fidalgo, Jose Alejandro Perez-Fidalgo +32 · 1 citation
Medicine · #Endometrial and Cervical Cancer Treatments #Cancer-related Molecular Pathways #Genetic factors in colorectal cancer